The role played by raised circulating immune complex (CIC) levels in the pathogenesis of rubella-associated joint reactions has been assessed during the course of RA 27/3 rubella immunisation and epidemic wild rubella infection. CIC levels were evaluated by Clq microplate enzyme-linked immunosorbent assay (ELISA) and Raji cell ELISA techniques. Mean CIC levels were generally higher both before and after immunisation among individuals developing vaccine-associated arthritis than among those developing arthralgia or no joint symptoms. However, these differences reached statistical significance only with CIC (Raji) techniques at six and 12 weeks postimmunisation. The proportion of individuals within each group having raised CIC levels (¢2SD above normal control values) was also higher in the postvaccine arthritis group, though statistically significant differences were not found with either Raji or Clq techniques. These data do not support a direct role for raised CIC levels in the pathogenesis of rubella-associated arthritis or arthralgia.
The pathogenesis of joint manifestations occurring during the course of infection with mild and vaccine strains of rubella virus has remained unclear despite numerous recent studies. 1-5 A possible role for increased levels of circulating immune complexes (CIC) in the development of joint symptoms has been suggested by the temporal association between the onset of joint manifestations and the appearance of circulating rubella-specific antibody.6 In addition, the detection of rubella virus persistence in peripheral blood mononuclear cells in patients with prolonged rubella-associated arthritis7 provides an opportunity for recurrent rubella virus antigenaemia and subsequent CIC formation. Preliminary experimental support for this hypothesis has been provided by the detection in rubella-associated arthropathy of Fig. iB) . Again, individuals developing acute polyarthritis had higher mean CIC (Clq) levels than those groups experiencing arthralgia or no joint manifestations in the postvaccine follow-up period. No statistically significant differences were noted in either mean CIC (Clq) levels between each patient group and the proportion of each group having raised CIC levels.
WILD RUBELLA INFECTION STUDIES
In contrast with CIC studies carried out in the rubella vaccine group, a more pronounced rise in CIC (Raji) and CIC (Clq) levels was observed at 0 and two weeks after wild rubella infection ( Table 2 , Figs 2A and B). Higher mean CIC levels were again observed among individuals developing joint manifestations postinfection than among those remaining asymptomatic during the follow-up period. These differences never reached levels of statistical significance.
Discussion
The present study does not support a clear relationship between raised circulating immune complex levels and the development of joint manifestations 
